Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Focusfreda, officially known as Shandong Focusfreda Biotech Co., Ltd., is a leading global manufacturer specializing in sodium hyaluronate (hyaluronic acid) and related bioactive substances. Based in Qufu, China, the company provides high-purity ingredients for the pharmaceutical, cosmetic, and food industries. Established in 2012 and later acquired by the Shandong Freda Pharmaceutical Group, Focusfreda utilizes advanced microbial fermentation and purification technologies to produce various grades of hyaluronic acid, including injection, cosmetic, and food grades. Their facility adheres to rigorous international standards, holding certifications such as GMP, ISO 9001, and COSMOS. The company serves as a vital supplier for healthcare products, medical devices, and high-end skincare formulations globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Focusfreda.